AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 135 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $34,000 | -87.6% | 1,661 | -88.0% | 0.00% | -100.0% |
| Q4 2018 | $275,000 | -16.9% | 13,822 | -19.7% | 0.01% | +33.3% |
| Q3 2018 | $331,000 | -17.7% | 17,214 | -34.7% | 0.01% | -14.3% |
| Q2 2018 | $402,000 | -49.3% | 26,359 | -37.7% | 0.01% | -61.1% |
| Q1 2018 | $793,000 | – | 42,299 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MQS Management LLC | 10,935 | $255,000 | 0.41% |
| GLOBEFLEX CAPITAL L P | 144,692 | $3,370,000 | 0.34% |
| CORNERCAP INVESTMENT COUNSEL INC | 58,975 | $1,374,000 | 0.20% |
| Factorial Partners, LLC | 10,900 | $254,000 | 0.17% |
| FEDERATED HERMES, INC. | 3,464,335 | $80,684,000 | 0.15% |
| Campbell & CO Investment Adviser LLC | 14,800 | $345,000 | 0.12% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 611,462 | $14,241,000 | 0.08% |
| Summit Global Investments | 45,900 | $1,069,000 | 0.07% |
| RENAISSANCE GROUP LLC | 63,559 | $1,480,000 | 0.06% |
| PDT Partners, LLC | 33,459 | $779,000 | 0.06% |